Mark Blagden
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 3
-
- Pain Management and Opioid Use 2
- Co-authors
- Michael Hopp (2 shared papers)Edward J. Czerwinski (2 shared papers)Kerry Palmer (2 shared papers)Eugene Vincent McCloskey (2 shared papers)Bernard Cortet (2 shared papers)Robert Kees Stad (2 shared papers)James O’Kelly (2 shared papers)Peyman Hadji (2 shared papers)
- Journals
- The Lancet (2 papers)International Journal of Clinical Practice (2 papers)Canadian Journal of Cardiology (1 paper)Diabetes Care (1 paper)Expert Opinion on Pharmacotherapy (1 paper)
- Partner nations
- United KingdomGermanySwitzerland
In The Last Decade
Mark Blagden
14 papers receiving 2.3k citations
Mark Blagden's Hit Papers
Peers
Comparison fields: 5 of 80
- Endocrinology, Diabetes and Metabolism 1.6k
- Nephrology 134
- Cardiology and Cardiovascular Medicine 320
- Orthopedics and Sports Medicine 115
- Anesthesiology and Pain Medicine 62
Countries citing papers authored by Mark Blagden
This map shows the geographic impact of Mark Blagden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Blagden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Blagden more than expected).
Fields of papers citing papers by Mark Blagden
This network shows the impact of papers produced by Mark Blagden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Blagden. The network helps show where Mark Blagden may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Blagden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2018 | 1445 |
| 2 | 2017 | 248 | |
| 3 | 2018 | 199 | |
| 4 | 2019 | 160 | |
| 5 | 2020 | 120 | |
| 6 | 2010 | 65 | |
| 7 | 2002 | 33 | |
| 8 | 2016 | 30 | |
| 9 | 2014 | 29 | |
| 10 | 2007 | 25 | |
| 11 | 2002 | 14 | |
| 12 | 2010 | 8 | |
| 13 | 2022 | 6 | |
| 14 | 2015 | 4 |
About Mark Blagden
Mark Blagden is a scholar working on Endocrinology, Diabetes and Metabolism, Anesthesiology and Pain Medicine, Orthopedics and Sports Medicine, Public Health, Environmental and Occupational Health and Surgery, having authored 14 papers that have together received 2.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Bone health and osteoporosis research (2 papers), Opioid Use Disorder Treatment (2 papers), Pain Management and Opioid Use (2 papers), Streptococcal Infections and Treatments (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Otolaryngology and Infectious Diseases (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Nephrology (134 citations), Cardiology and Cardiovascular Medicine (320 citations), Orthopedics and Sports Medicine (115 citations) and Anesthesiology and Pain Medicine (62 citations). Mark Blagden has collaborated with scholars based in United Kingdom, Germany and Switzerland. Frequent co-authors include Michael Hopp, Edward J. Czerwinski, Kerry Palmer, Eugene Vincent McCloskey, Bernard Cortet, Robert Kees Stad, James O’Kelly, Peyman Hadji, Juraj Payer and Socrates E. Papapoulos. Their work appears in journals such as The Lancet, International Journal of Clinical Practice, Canadian Journal of Cardiology, Diabetes Care and Expert Opinion on Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.